This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Lilly Toker
Introduction
Lilly Toker is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of biochemistry, particularly in the study of glucocerebrosidase molecules. Her work focuses on developing methods to correct impaired enzymatic activities associated with mutant glucocerebrosidase.
Latest Patents
Lilly Toker holds 1 patent for her invention titled "Partially deglycosylated glucocerebrosidase polypeptide and crystals thereof." This patent describes a method for identifying compounds that can correct the impaired enzymatic activity of mutant glucocerebrosidase molecules. The method involves obtaining a 3D structure of a normal glucocerebrosidase molecule and computationally generating a predicted structure for the mutant version. By identifying compounds that interact with the mutant enzyme, Lilly's work aims to restore its enzymatic function.
Career Highlights
Lilly Toker is associated with Yeda Research and Development Co. Ltd., where she continues to advance her research. Her innovative approach to enzyme activity correction has the potential to impact therapeutic strategies for diseases related to glucocerebrosidase deficiencies.
Collaborations
Lilly has collaborated with notable scientists in her field, including Anthony Futerman and Joel L. Sussman. These collaborations have enriched her research and contributed to the advancement of knowledge in enzymatic functions.
Conclusion
Lilly Toker's contributions to the field of biochemistry through her innovative patent and collaborative efforts highlight her role as a leading inventor. Her work not only enhances our understanding of glucocerebrosidase but also paves the way for potential therapeutic advancements.